Joe Silver
Forumer storico
A fourth dose of a Covid-19 vaccine boosts antibodies but isn’t enough to prevent Omicron infections, according to a preliminary study in Israel.
Researchers at Sheba Medical Center near Tel Aviv studied the effect of the Pfizer (ticker: PFE) vaccine on 154 medical staff after two weeks, and the Moderna (MRNA) booster on 120 volunteers after one week, the Times of Israel reported.
Researchers at Sheba Medical Center near Tel Aviv studied the effect of the Pfizer (ticker: PFE) vaccine on 154 medical staff after two weeks, and the Moderna (MRNA) booster on 120 volunteers after one week, the Times of Israel reported.